NEW DELHI: Gilead Sciences Inc is eyeing studies on use of remdesivir with other drugs to understand if such combinations would aid patient recovery. “Beyond the ongoing studies of remdesivir, we look forward to the initiation of combination studies of remdesivir to understand whether the addition of other drugs may enhance patient outcomes," Gilead Sciences Inc said in a statement on Monday.
The statement comes on the back of the preliminary results from the National Institute of Allergy and Infectious Diseases’ (NIAID) study on use of remdesivir for the treatment of covid-19 were published in the peer-reviewed New England Journal of Medicine.